Biogaran Claims Lead On French Biosimilars
But Uptake Remains Low In Outpatient Setting
Biogaran says it has cemented its position as the market leader for hospital biosimilars in France, pointing to high penetration levels for biosimilars in the hospital setting in general. However, the firm says, more efforts are needed to encourage uptake in the outpatient setting, including pharmacy-level substitution.
